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Malignant melanoma, as the name implies,
is a malignant tumor of melanocytes, found in
the skin, eyes, meningeal lining and the
mucosal epithelium of the aero-digestive and
genitourinary tracts. Malignant melanoma is
typically skin malignancy, which rarely pres-
ents at extracutaneous site. Here we present a
rare case of primary retroperitoneal melanoma
and review the findings in comparison with
other cases described in literature.
Introduction
Primary retroperitoneal melanoma (PRM) is
an exceptionally rare extracutaneous malig-
nant melanoma. PRM cases are mostly inci-
dental finding. Only three cases of PRM have
been reported in the English literature.1-3
Although malignant melanoma is typically a
skin malignancy, it still appears in other
organs, where melanocytes can be found
(eyes, meninges and the lining of aero diges-
tive tracts).4,5 Atypical extracutaneous
melanomas are either metastatic melanoma of
unknown primary or very rarely, primary
melanoma. Primary extracutaneous melanoma
constitutes 4-5% of melanoma cases.4-6
Case Report
A 53-year-old Caucasian female, with no sig-
nificant comorbidities except for well-con-
trolled hypertension and hypothyroidism, pre-
sented with postmenopausal vaginal bleeding.
Transvaginal ultrasound revealed left side
complex pelvic mass measuring 4.3×3.4×3 cm,
with differential diagnosis of either complex
cystic or solid adnexal mass. So, laparoscopic
hysterectomy and bilateral salpingo-oophorec-
tomy was performed along with removal of left
pelvic mass, pelvic lymph node dissection and
omentectomy. She tolerated the procedure well
and was discharged shortly thereafter. Gross
examination of the pelvic mass showed a fatty
nodule measuring 7.3×5.5×3.3 cm and weigh-
ing 78 g (Figure 1A). The serial sectioning
revealed tan-white to red-brown cut surfaces
(Figure 1B). Histopathological examination
showed neoplastic proliferation of spindled
cells with ovoid vesicular chromatin, visible
nucleoli, indistinct cell borders, apoptosis, geo-
graphic necrosis and mitoses. There were scat-
tered clusters of pigment-laden histiocytes
with very dark pigment material. Lymphocytes
were seen scattered throughout the tumor
(Figure 2). Immunohistochemical (IHC) stain-
ing was done with appropriately staining con-
trols and showed the following results; HMB45:
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Figure 1. A) Gross pathology of pelvic mass. Whole pelvic mass, post-formalin fixation,
inked black and serially sectioned, showing fleshy, variegated gray-tan and gray-white cut
surfaces; B) gross pathology of pelvic mass. Slice of tumor near one end showing discrete,
black, lobulated sub capsular area at top right.
A
B
Positive, Melan-A: Positive, S100: Positive and
Cytokeratin: Negative (Figure 3). No other
pathology was identified among other parts
including pelvic lymph nodes.
The histomorphological features and IHC
staining pattern were most consistent with the
diagnosis of a malignant melanoma. Given the
pelvic retroperitoneal location of the mass, this
was thought to be a metastatic deposit. 
Due to the rarity of her presentation and
lack of evidence based guidelines for further
work up, an extensive work up was performed
to search for an occult primary and involve-
ment of other sites. Detailed skin examina-
tion, positron emission tomography - comput-
ed tomography scan, magnetic resonance
imaging brain, colonoscopy and esophageal-
gastro-duodenoscopy did not reveal any abnor-
malities. Further pathology studies did not
reveal BRAF or C-Kit mutation. Hence, diagno-
sis of primary retroperitoneal melanoma was
made. The patient was offered adjuvant
immunotherapy (interferon) as in high risk
cutaneous melanoma; however, she opted for
observation after considering the treatment
toxicities and survival data.
Discussion
Very few cases of PRM have been reported
in medical literature.1-3 Due to its unusual
location, the diagnosis of extracutaneous
malignant melanomas is a challenge. In fact, it
is more difficult to diagnose PRM because the
retroperitoneum does not contain
melanocytes. The large space of the retroperi-
toneal cavity provides ample room for the solid
tumors to grow without being noticed, and
thus it rarely remains the only site of disease.
Due to rarity of PRM there is no established
recommendation for diagnostic workup and
therapeutic options. 
The diagnosis of PRM is possible only after
histopathological examination and IHC stud-
ies. However, histopathology cannot determine
whether melanoma presenting retroperitoneal
mass is PRM or metastasis from cutaneous or
visceral melanoma. In 1976, Ainsworth and col-
leagues7 and, subsequently, in 1984, Carstens
and colleagues8 established a series of criteria
to distinguish between primary and metastatic
malignant melanomas. 
Conclusions
The possibility of PRM must be kept in mind
while evaluating an unexplained solid
retroperitoneal mass and the diagnosis con-
firmed by IHC. Despite the fact that melanoma
can have varied presentations, PRM is still a
very rare entity among extra cutaneous malig-
nant melanomas.
This case has been highlighted for its rarity
and unusual presentation and must be includ-
ed among the few reported cases of PRM.
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Figure 2. A) Hematoxylin-eosin (H&E) slides: spindled cells and ovoid cells comprising
the hypercellular tumor; B) H&E slides: tumor cells with melanin pigment (brown).
Figure 3. A) Immunostaining with HMB45 (+melanocytes); B) immunostaining with
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